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Summary 
Human  natural  killer  (NK)  cells  express  inhibitory receptors that  are  specific for different 
groups of HLA-C or HLA-B alleles.  The majority of these receptors belong to the immuno- 
globulin (Ig) superfamily and are characterized by two or three extracellular Ig-hke domains. 
Here we describe a novel inhibitory NK receptor that is specific for a group of HLA-A alleles. 
The HLA-A3-specific NK cell clone DP7 has been used for mice immunization. Two mAbs, 
termed Q66 and Q241, bound to the immunizing clone and stained only a subset of NK cell 
populations or clones. Among Q66 mAb-reactive clones, we further selected those that did not 
express any of the previously identified HLA-class I-specific NK receptors. These clones did 
not lyse HLA-A3 + (or -All +) target cells, but lysis of these targets could be detected in the 
presence of Q66 or Q241  mAbs. On the other hand, target cells expressing other HLA-A al- 
leles, including -A1, -A2, and -A24, were efficiently lysed. Moreover, none of the HLA-C or 
HLA-B alleles  that  were  tested  exerted a  protective effect.  Q66  +,  but  not  Q66-  NK  cell 
clones, expressed messenger RNA coding for a novel 3 Ig domain protein homologous to the 
HLA-C (p58) and HLA-B (p70) receptors. The corresponding cDNA (c1.1.1) was used to gen- 
erate transient and stable transfectants in COS7 and NIH3T3 cell lines, respectively. Both types 
of transfectants were specifically stained by Q66 and Q241 mAbs. Since the cytoplasmic tail of 
Q66-reactive molecules was at least 11 amino acid longer than the other known p58/p70 mol- 
ecules, we could generate an antiserum specific for the COOH-terminus of Q66-reactive mol- 
ecules, termed PGP-3. PGP-3 immunoprecipitated, only from Q66 + NK cells, molecules dis- 
playing a molecular mass  of 140 kD,  under nonreducing conditions, which resolved, under 
reducing conditions, in a 70-kD  band.  Thus, differently from the other p58/p70  receptors, 
Q66-reactive  molecules  appear  to be  expressed as  disulphide-linked  dimers  and  were  thus 
termed p140.  The comparative analysis  of the amino  acid sequences of p58, p70, and p140 
molecules revealed the existence of two cysteins proximal to the transmembrane region, only 
in the amino acid sequence of p140 molecules. 
N 
K cells are thought to play a relevant role in the host 
defenses because of their ability to kill certain tumor 
or virally infected cells (1). The molecular mechanisms that 
explain why NK cells do not kill indiscriminately but spare 
normal (self) cells have recently been elucidated. It reflects 
the expression of different specialized receptors that recog- 
nize allelic  forms of MHC  class I molecules expressed on 
normal cells. This interaction leads to the generation of an 
inhibitory signal  that prevents  target  cell lysis  (2--6).  Ac- 
cordingly, the lack of expression of one or more class I al- 
leles  (as  it may occur in  tumor or virally infected cells), 
leads  to  NK-mediated  target  cell  lysis.  So  far,  different 
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(p58  molecules) or HLA-B  (p70/NKB1  molecules) alleles 
have  been  identified (7-10).  Thus,  p58.1  molecules reac- 
tive with the EB6 mAb recognized a group of HLA-C al- 
leles (HLA-Cw2,  -Cw4,  -Cw5,  and -Cw6),  characterized 
by the  amino  acid residues N77/K80  (4).  p58.2  (reactive 
with GL183 mAb) recognized HLA-Cwl,  Cw3, Cw7, and 
Cw8 alleles characterized by $77/N80  (4). p70/NKB1  rec- 
ognized a  group  of HLA-B  alleles belonging to  the  Bw4 
supertypic specificity (e.g., HLA-B2705,-B51,-B58,  and 
-B44)  (9,  10).  Cloning  of these  receptors  revealed  new 
members of the Ig superfamily, characterized by two  (p58) 
or three (p70/NKB1)  lg-like domains in their extracellular 
portions  and  by  a  long  cytoplasmic tail associated with  a 
nonpolar transmembrane  (11-13).  The  cytoplasmic tail is 
characterized by an immuno tyrosine-based activatory mo- 
tif (ITAM)t-like sequence in which two YXXL amino acid 
motig are spaced by 26 amino acids (instead of six to eight 
typical of ITAMs of CD3  molecules) (14).  CD94,  another 
putative receptor involved in HLA class I recognition, dis- 
plays a  different structure.  Similar to  Ly49, the mouse  re- 
ceptor for MHC  class I molecules, it belongs to the type 2 
transmembrane proteins containing a C-type lectin domain 
(15,  16).  So far,  only receptors for HLA-C or HLA-B al- 
leles have been identified; however,  evidence for an NK- 
mediated recognition of HLA-A alleles has been provided 
both in fresh (17) and cloned NK cells (18). 
In the present paper, we selected two mAbs that identify 
a  receptor  recognizing  HLA-A3,  but  not  -A1,  -A2,  and 
-A24 alleles. Similar to other HLA class I-specific NK re- 
ceptors, this receptor is expressed on a subset of NK cells, 
and it inhibits the NK-mediated cytolysis upon interaction 
with its specific ligand. Different from the other NK recep- 
tors,  Q66  is  expressed  at  the  NK  cell  surface  as  a  disul- 
phide-linked dimer of 140 kD (thus termed p140).  In addi- 
tion,  molecular analysis revealed a  new  member of the  Ig 
superfamily, characterized by three extracellular lg-like do- 
mains  and  a  nonpolar  transmembrane  portion  associated 
with  a  95-amino  acid  cytoplasnfic  tail  containing  an 
ITAM-like motif. 
Materials and Methods 
NK Clones and Populations.  PBL derived from healthy donors 
were isolated on  Ficoll-Hypaque gradients, and cells were then 
incubated with a mixture ofLeu4, Leu3a, and Leu2a mAbs for 30 
nfin at 4~  followed by treatment with goat anti-mouse-coated 
Dynabeads (Dynal, Oslo, Norway) for 30 rain at 4~  Next, after 
imnmnomagnetic depletion, CD3  4  8- cells were cloned under 
limiting dilution conditions in the presence of irradiated feeder 
cells, (i).l% (vol/vol) PHA (Gibco Ltd., Paisley, Scotland), and ex- 
ogenous IL2 (rIL-2; Cetus Corp., Emeryville, CA), as previously 
described (19). CD3-56 § 16 § polyclonally activated NK cell pop- 
ulations were obtained plating 104 CD3-4-8- cells per well at the 
same culture conditions. 
t  Abbreviations used in this paper: ITAM, immuno tyrosine-based activatory 
motif; ORF, open reading frame; RACE, rapid amplification of cDNA 
elldS. 
Production ofmAbs.  5-wk-old male BALB/c mice were im- 
munized with the NK cell clone DP7  (surface phenotype: CD3- 
CD16+CD56+GL183-EB6-Z27-),  as previously described (7). 
The screening ofhybridoma supernatants was based on the ability 
to reconstitute the cytolytic function of the DP7 clone against the 
C1R/A3  transfectant used  as 5~Cr-labeled  target cells  in  a  4-h 
SlCr release assay, as previously described in detail (7). According 
to  this screening procedure,  two  hybridomas termed Q66  and 
Q241  were selected and further subcloned in limiting dilution. 
Both were of the IgM isotype. 
mAbs and Flow Cytometry.  In this study, the following mAbs 
were used: Leu4  (IgG  l anti-CD3), Leu3a (IgGi anti-CD4), and 
Leu2a (IgGi anti-CDS), purchased by Becton Dickinson & Co. 
(Mountain  View,  CA);  GL183  (IgG  1 anti-p58.2),  EB6  (IgG  1 
anti-p58.1), XA-141  (IgM anti-p58.1),  c127  (lgG~ anti-CD16), 
c218  (IgGi  anti-CD56),  A6-136  (IgM  anti-HLA class I),  Z27 
(IgGi anti-p70/NKB1), XA185  (IgG  1 anti-CD94),  and A6-220 
(IgM anti-CD56) were obtained in our lab (7-9, 20-22). 
Analysis of PBL or polyclonally activated NK cell populations 
for the distribution of the surface antigen recognized by the Q66 
mAb, was performed using two-color fluorescence  cytofluorimetric 
analysis  (FACSort  |  Becton Dickinson), as previously described 
(8).  Cells were stained with Q66  mAb, followed by PE-conju- 
gated goat anti-mouse IgM antibodies (Southern Biotechnology 
Associates, Birmingham, AL), and the other mAb, either Leu4, 
c127,  GL183 and EB6, or Z27 antibodies, followed by appropri- 
ate anti-lgGl-FITC antibodies. 
Modulation of Surface Molecules.  Flat-bottommed plates (24 wells/ 
plate; Costar Corp., Cambridge, MA) were coated with  10 p~g/ 
ml (1  nal) XA-141  mAb (anti-p58) during overnight incubation 
at 4~  as previously described (20).  Cloned NK cells (106) were 
added to  coated or  uncoated  wells and  incubated  for  18  h  at 
37~  Cells were then washed twice and analyzed for indirect im- 
munofluorescence on a flow cytometer by a FACSort  | 
CFtolytic Assay.  The cytolytic activity of cloned NK cells was 
measured in a 4-h 5fCr-release assay in which effector cells were 
tested against the  CIK  B-LCL  human  cell line  (5)  (HLA-A  , 
-B351~  -Cw4 +)  and  CIR  transfectants  expressing  HLA-A1, 
-A2,  -A3,  -A24,  -B51,  -B7,  and  -B27  (kindly provided by P. 
Cresswell, Yale University, New Haven, CT;  B.  Biddison, Na- 
tional Institutes of Health, Bethesda, MD andJ.A. Lopez De Cas- 
tro, Fundacion Yimenez Diaz, Madrid, Spain). Other target cells 
used in these studies were represented by the B-EBV  cell lines 
HOM2  (homozygous haplotype: HLA-A3; -B27; -Cwl), SP0010 
(homozygous haplotype: HLA-A2;-B44;-Cw5), and WT100BIS 
(homozygous haplotype: HLA-A11; -B35;  -Cw4),  provided by 
Dr. G.B. Ferrara (Istituto Scientifico Tumori, Genova, ltaly) and 
the  B-EBV  A51  (haplotype: HLA-A2; -B18,  15;  -Cw3,7)  de- 
rived from  a  normal  HLA-typed individual (Table  1)  (4). All 
these target cells were used at 5 ￿  103/well at the final E/T ratio 
of 4:1.  The percent of specific lysis was detemfined as previously 
described (4). mAbs were added at the onset of the cytolytic assay 
before adding target cells.  The  concentrations of Q66  and A6- 
136 mAbs used in the various assays were 2 ~g/ml and 5{){} ng/ 
ml, respectively. 
cDNA Library Construction1 and Size Fractionation.  RNA was pre- 
pared from CD3-16 § NK cells by the guanidinium thiocyanate/ 
CsC1 method,  and  cDNA  was  synthesized from  8  ~xg  of the 
poly(A)  + fraction by the method of Gubler and Hoffman  (26). 
The cDNA was inserted into the CDM8 vector using non-self- 
complementary BstXI  adapters (26),  and the ligated DNA was 
transformed into competent Escherichia coli MC 1061/p3.  100 p~g 
of the amplified library were then linearized with Notl and size 
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Target Cells 
HLA classs l haplotype 
B-EBV 
cell line  Locus A  Locus B  Locus C 
HOM2*  A3  B27 (Bw4)*  Cwl ($77/N80)5 
WT100BIS*  All  B35 (Bw6)  Cw4 (N77/K80) 
SP0010*  A2  B44 (Bw4)  Cw5 (N77/K80) 
A51  A2,A2  B18,B15,  (Bw6)  Cw3,7 ($77/N80) 
*Homozygous B-EBV cell line. 
*Indicates the supertypic specificity  of the expressed HLA-B allele. 
~Indicates the amino acid residues at positions 77 and 80 of the ex- 
pressed HLA-C allele. 
fractionated  using a 0.8% agarose gel.  12 different fractions were 
religated  after  Gene-Clean (Bio  101,  La Jolla,  CA)  purification 
and transformed into MC 1061/p3 by electroporation at 2,500 V, 
200 f~, and 25 IxF (26) using a Bio-Rad apparatus (Bio-Rad Lab- 
oratories srl, Milano, Italy). 
Isolation of cDNA  Clones Encoding 3  Ig Domain  NK Receptors. 
Replicas  were made on t37-mm nylon filters (MSI,  Westboro, 
MA) and prepared for hybridization as described  (26). The filters 
were hybridized with a 403-bp cDNA probe (nucleotides 88-491 
of 183c16 sequence).  Different recombinant cDNA clones  were 
identified, subcloned, and plasmid DNA was isolated as described 
(27). The 5'-end nucleotide sequences  of 17.1 and 8.11 cDNAs 
were checked by rapid amplification of cDNA ends (RACE) (28). 
Amplification of Specific cDNAs fiom NK Cell Clones.  Total RNA 
was extracted  using RNAzol (Cinna/Biotecx, Houston, TX) by 
standard procedure, cDNA was obtained by reverse transcription 
reaction using oligo dT priming. Primers used for cDNA amplifi- 
cation  were  5'  ACGTTCCCATCTTCCA(TC)G (backward) 
and 5'  GCT(AG)CAGGACAAGGTCAC (forward).  The set of 
primers  (0.5 p~M) was used in a 30 cycles PCR including 15 cy- 
cles at 30 s 94~  30  s 65~  30  s 72~  and 15  cycles at 30  s 
94~  30 s 60~  30 s 72~  followed by an extension of 7 rain at 
72~  cDNA fragments  were subcloned into pCRII vector (In- 
vitrogen, San Diego, CA) and sequenced. 
Dot Blot Hybridization.  Amplified  fragments  were  denatur- 
ated  in 0.45  N  NaOH,  spotted onto nylon membrane (Gene- 
Screen Plus NEN DUPONT, Boston, MA), and hybridized with 
the following 32p-labeled oligonucleotides: 5'  CTA CAG ATG 
TTA TGG TTC TGT T  (probe  Q)  and 5'  TAC AGA TGC 
TAC GGT TCT GT (probe  Z). Hybridization was carried  out 
for 4 h at 56~  in 0.1% SDS,  5X  Denhardt's solution, and 4X 
SSPE (27) (probe  Q)  or 5x  SSPE (probe  Z). Membranes were 
washed in 0.1% SDS and 0.1X SSPE for 10 rain at room temper- 
ature and for 10 rain at 42~  (probe Z) or 44~  (probe Q). 
Isolation of Full-length cDNAs.  The sequences of the  forward 
primers used to obtain complete open reading frame (ORF) am- 
plification products  were  5'  CATGT(CT)GCTCA(CT)GGT- 
CGTC (Ig3Up forward),  and 5' GGTTTTGAGACAGGGCTG 
(Ig3Down backward).  The PCR cycling condition used was  15 
cycles at 20 s 94~  30 s 65~  30 s 72~  and 15 cycles at 20 s 
94~  30 s 60~  30 s 72~  followed by an extension of 7 rain at 
72~  The  5'  end nucleotide sequences  of c1.17.1, c1.1.1, and 
cl.AMC5 cDNAs were checked by RACE (28). cDNA fragments 
were subcloned into pCR3 vector (Invitrogen) and sequenced. 
Transient Transfectants.  The  monkey  COS7  cell  line  (5  ￿ 
10S/plate)  was  transfected  by the  DEAE-dextran method with 
pCIk3-cl.lA and pCR3-AMC5 cDNA constructs.  In particular, 
5 ￿  10  s COS7 cells were incubated in DMEM/0.1 mM chloro- 
quine phosphate/0.5 mg/ml DEAE-dextran in the presence of 10 
b~g of plasmid DNA at 37~  After 3 h, the transfection mixture 
was replaced by DMEM/10% FCS. After 48 h, transfectants were 
trypsinized,  stained  with  Q66,  Q241,  z27,  EB6,  and  GL183 
mAbs,  followed by a  PE-conjugated goat  antibodies to  mouse 
IgM or IgG1 and analyzed by a FACSort  | 
Stable Transfectants.  Subconfluent NIH3T3 cells were  trans- 
fected by the calcium phosphate  technique with the cDNA con- 
struct pCR3-cl.l.1, as already described  (27). 48 h after transfec- 
tion, the cells were selected in G418 (1 mg/ml). 2 wk later, cells 
were  analyzed  for cell-surface  expression  with  Q66  and Q241 
mAbs, sorted, and subcloned. 
Western Blot Analysis.  Cells were lysed for 30 rain on ice in a 
buffer  containing 1% NP40,  50  mM Tris-HC1, pH 7.5,  0.3  M 
NaCI, 1 mM PMSF, 10 mM iodoacetamide. Lysates were run on 
a 8.5% polyacrytamide  gel under reducing (5% 13-mercaptoetha- 
nol) or nonreducing conditions. Gel was blotted in transfer buffer 
(25 mM Tris-HC1,  pH 8.3/0.2 M glycine in 20% vol/vol metha- 
nol)  on  a  polyvinyldifluoride membrane (Immobilon-P; Milli- 
pore Corp., Bedford,  MA) at 125 mA for 1 h. The blot was satu- 
rated  with TBS  (0.15 M  NaC1/20 mM Tris-HCl, pH 7.5)/3% 
nonfat dried milk overnight at 4~  The blot was incubated with 
PGP3 antiserum (1:200 dilution) for 2 h followed by a 1-h incu- 
bation with a 1:10,000  dilution of a goat anti-rabbit IgG conju- 
gated to alkaline phosphatase (Tropix Inc., Bedford, MA). Chemi- 
oluminescent detection  was  performed  using  CSPD  substrate 
(Tropix)  following the  manufacturer's instructions. X-ray films 
were exposed  at room temperature for some minutes to detect 
the chemiluminescence. 
PGP3 PolyclonalAntiserum.  A  2.5-kg  HY/Cr  male  rabbit 
(Charles River Laboratories,  Wilmington, MA)  was immunized 
with  100  p~g/100 }*1  of the  15-amino acid  peptide VSCPRA- 
PQSGLEGVF  (MedProbe,  Oslo,  Norway)  conjugated  with 
KLH. Four treatments were perfbrmed at 1-wk intervals; the first 
one was in association with 100 b~l CFA, the other ones in associ- 
ation with 100 ILl IFA. After 1 wk from the last treatment, 10 ml 
of blood was  drawn  and the  serum was  tested  and  titered by 
ELISA against the immunizing  peptide and irrelevant ones. Other 
immunizations  followed at 2-wk intervals. 
ELISA.  The peptide used for immunization  and two nonrel- 
evant peptides  were diluted in 10 mM phosphate  buffer, pH 7.0 
(5  I.tl/ml  and attached  to a polyvinylchloride plate  (50 }*l/well) 
overnight at 4~  The plate was saturated with 3% BSA/PBS and 
incubated with  scalar dilutions of preimmune serum  or  PGP3 
antiserum, followed by a horseradish peroxidase-labeled  goat anti- 
rabbit Ig antibody (1:5,000). Positivity was detected after incuba- 
tion with ABTS substrate (Boehringer Mannheim, GmbH, Mann- 
heim, Germany) and reading of the plate at 405 nm. 
Results 
Selection  of mAbs  Identifying  an  HLA-A3-specific  NK  Re- 
ceptor.  In an attempt to identify NK cell clones specific for 
HLA-A molecules, we analyzed a large panel of clones de- 
rived from different individuals for their cytolytic activity 
against target cells transfected with different HLA class I al- 
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Figure  1.  Cell distribution of 
Q66  mAb-reactive  molecules. 
(A)  Two-color cytofluorimetric 
analysis of  the  distribution  of 
Q66-reactive molecules in PBL. 
Cells  were  stained  with  Q66 
mAb followed by PE-conjugated 
goat anti-mouse  IgM and with 
anti-CD3  (Leu4 mAb, IgGi) or 
anti-CDl6  (c127 mAb,  IgG0 
followed  by  FITC-conjugated 
goat anti-mouse IgG1. The con- 
tour  plots  were  divided  into 
quadrants representing unstained 
cells (lower  leO), cells with  only 
red fluorescence (upper left),  cells 
with red and green fluorescence 
(upper  right),  and cells with only 
green  fluorescence (lower  right). 
(B)  Two  color-cytofluorimetric 
analysis of  the  distribution  of 
Q66 mAb-reactive molecules in 
a  cultured  CD3-  56+16  +  bulk 
population.  Cells  were  stained 
with Q66 mAb followed by PE- 
conjugated goat anti-mouse IgM 
and with a mixture of  GL183 and 
EB6  (anti-p58.2  +  anti-p58.1, 
both  IgG  0  or  Z27  (anti-p70, 
IgGi) mAbs followed by FITC- 
conjugated  goat anti-mouse lgG~. 
leles. To  this end,  C1P,  (Cw4 +)  cells either untransfected 
or transfected with HLA-B7, -B27,  -B51,  -A1, -A2, -A3, 
or -A24 have been used as target cells. Other target cells in- 
cluded 221  cells transfected with HLA-Cw3 or -Cw4 (26). 
Among the HLA-A alleles analyzed, HLA-A3 appeared to 
exert the  most  marked protective effect.  The  majority of 
HLA-A3-specific clones,  however,  also  recognized other 
HLA class I alleles and expressed the corresponding recep- 
tors.  However,  mAbs  to  these  receptors,  including  EB6 
(anti-p58.1)  (8),  GL183  (anti-p58.2)  (7),  Z27  (anti-p70) 
(9),  and  XA185  (anti-CD94)  (22)  did not  restore lysis of 
CIP,-A3 target cells. To facilitate the identification of the 
receptor molecule(s) involved in HLA-A3 recognition, we 
selected NK clones displaying specificity only for HLA-A3 
molecules.  Among these  NK  clones,  the  DP7  clone  was 
further  expanded and used for mouse  immunization.  The 
hybridoma supernatants were first screened for their ability 
to  reconstitute lysis of C1P,-A3  by the  immunizing DP7 
clone.  Selected mAbs were further analyzed for their pat- 
tern of reactivity with DP7 clone, CIR-A3 target cells, as well 
as other NK cell clones specific or not for the HLA-A3 al- 
lele. mAbs Q66 (IgM) and Q241  (IgM) specifically reacted 
with  the  immunizing DP7  clone.  In  addition,  they were 
found to selectively stain NK clones (derived from different 
individuals) displaying HLA-A3 specificity. 
Analysis of the cell distribution of the surface molecules 
Figure 2.  (A) Expression of Q66  mAb-reactive molecules in  NK cell clones. Four different Q66 + clones were  analyzed by indirect immuno- 
fluorescence for the expression of the NK receptors recognized by EB6 (p58.1), GL183 (p58.2), and Z27 mAbs (p70/NKB1). (B) Independent expres- 
sion of Q66 mAb-reactive molecules and p58.1 receptors in a representative NK cell clone. DA8 clone (EB6  +, GL183-, Z27-, Q66 +) was further ana- 
lyzed after mAb-mediated modulation of EB6 molecules (see Materials and Methods): Q66  mAb-reactive molecules do not comodulate with EB6 
molecules. Dark profiles represent the mAb-reactive cells. White profiles represent cells stained with the isotype-specific  anti-mouse antiserum. 
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XA141  Q66 recognized by Q66 and Q241  mAbs revealed an identical 
pattern of reactivity both in polyclonal NK cell populations 
and  NK cell  clones.  Since  Q66  mAb  consistently gave a 
brighter  staining  than  Q241  mAb,  immunofluorescence 
studies were carried out primarily with this mAb. Fig.  1 A 
shows  the  pattern  of reactivity  of Q66  mAb  with  fresh 
PBL:  it  is  evident  that  Q66 +  cells  represent  a  subset  of 
CD16 + NK cells.  In addition,  a small but sizeable fraction 
ofCD3 + cells coexpressed Q66. This type of distribution is 
similar to that of previously described HLA class I-specific 
NK  receptors,  including  p58.1,  p58.2,  p70/NKB1,  and 
CD94 molecules (7-10, 23-25).  Fig.  1 B shows a cultured 
polyclonal population  enriched  in  CD3-16 +  cells.  Q66 + 
cells stained only a fraction of the cell population analyzed; 
moreover, these cells could be distinguished from cells ex- 
pressing p58 molecules (as revealed by staining with a mix- 
ture of EB6 and GL183 mAbs) or p70/NKB1  (as revealed 
by staining with Z27 mAb). Fig.  2 A  shows four represen- 
tative  CD3-16 +  Q66 +  NK cell  clones.  Clone  DP7  (i.e., 
the  immunizing  clone)  reacted  with  Q66  mAb,  but  not 
with  mAbs  specific  for other  NK receptors.  Clone  M56 
coexpressed p70/NKB1, while clones DA8 and DA35 co- 
expressed p58.1  or both p58.1  and p58.2 receptors, respec- 
tively.  In Fig.  2  B we further analyzed whether,  in  clone 
DA8, Q66 and p58.1  molecules were associated at the cell 
surface. The XA141  mAb  (anti-p58.1,  IgM) induced  sur- 
face  modulation  of p58.1  molecules,  as  revealed  by  the 
sharp reduction in fluorescence intensity (using either EB6 
or  XA141  mAb).  In  contrast,  the  surface  expression  of 
Q66-reactive  molecules  was  unchanged  (20).  These  data 
indicate  that the  two  molecules are  not physically associ- 
ated at the cell surface. 
Q66  + NK Clones Display Specificity  for the HLA-A3  Al- 
lele.  The  following  experiments  have  been  designed  to 
define  whether  the  Q66  mAb-reactive molecules  indeed 
represented the NK receptor for the  HLA-A3 allele.  In a 
first group of experiments, NK clones that did not recog- 
nize HLA-C or HLA-B alleles  (and did not express p58 or 
pT0 molecules) were analyzed for their reactivity with Q66 
mAb. Q66 + and Q66-  clones that belong to this selected 
group were first analyzed for their ability to lyse four B-EBV 
cell lines, selected among 15  cell lines characterized by ei- 
ther homozygous or heterozygous HLA class I haplotypes. 
Selection was based on the expression of appropriate com- 
bination of HLA-A, -B, and -C alleles.  It is evident (Fig.  3 
A) that two cell lines (HOM2 and WT100BIS) were resis- 
tant to lysis by Q66 § clones, while the other two (SP0010 
and  A51)  were  efficiently lysed.  According  to  the  HLA 
haplotype of the four B-EBV target cell lines (see Table 1), 
it is possible to conclude that neither HLA-C nor HLA-B 
alleles are involved in the protective effect. Indeed, the two 
protected  cell lines  expressed  Cw1  or  Cw4,  respectively, 
belonging to the NK-defined HLA-C specificities, charac- 
terized  by  $77/N80  and  N77/K80,  respectively  (4,  29); 
moreover,  they  expressed HLA-B27  or -B35,  which  be- 
longed to the Bw4 or Bw6 supertypic specificities, respec- 
tively.  The  analysis  of the  expressed  HLA-A alleles  sug- 
gested that  HLA-A3 and HLA-All  conferred protection. 
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The target cell lines that were susceptible to lysis expressed 
HLA-C and HLA-B alleles  belonging to the  same groups 
of the protected targets, but lacked HLA-A3 or -All  (they 
were both homozygous for HLA-A2).  These data suggest 
that the  HLA-A3 and -A11,  but not -A2,  are recognized 
by Q66 + clones. The Q66-  clones lysed, with similar eff￿ 
ciency, HOM2 and SP0010 cell lines, expressing HLA-A3 
and -A2, respectively (Fig.  3  B).  To further document the 
specificity of Q66 + clones, they were analyzed for the abil- 
ity to lyse CllL cells transfected with different HLA-A al- 
leles,  including-A1,  -A2,-A3,  and-A24  (-All  was  not 
available). Q66 + clones efficiently lysed C11L cells untrans- 
fected or transfected with HLA-A1, -A2 (Fig. 3 C), and -A24 
(not shown).  In contrast,  the  expression of HLA-A3 con- 
ferred protection from lysis (>50% inhibition of lysis).  On 
the other hand,  Q66- clones (Fig.  3 D) efficiently lysed all 
the  above  transfected  target  cells.  Although  not  shown, 
C1P, cells transfected with HLA-B7 or HLA-B2705 alleles 
or 221  cells transfected with Cw3 or Cw4 alleles were effi- 
ciently lysed by all  Q66 §  clones used above (not shown). 
Thus,  the  cell distribution  of Q66-reactive molecules,  to- 
gether with the pattern of cytolysis of Q66 + versus Q66 
NK  clones,  strongly  suggested  that  Q66  mAb-reactive 
molecules  represent  the  receptor  for  the  HLA-A3  allele. 
We further analyzed whether the addition of Q66 mAb to 
the cytolytic assay could restore lysis of HLA-A3-protected 
targets by Q66 §  NK cell  clones.  Table  2  shows  the  cy- 
tolytic  activity of a  group  of representative  Q66 +  clones 
against  HLA-A3 +  (C1P,-A3  and  HOM2)  or HLA-A11 + 
(VgT100BIS) target cells (the HLA-A2 + SP0010 target cells 
lacking A3 and A11  alleles were used as control).  It is evi- 
dent that addition of Q66 mAb resulted in target cell lysis. 
As a control,  we used the anti-class I mAb A6-136  (IgM) 
previously shown to  efficiently interfere with the  interac- 
tion between HLA class I molecules and NK receptor (21) 
and the anti-CD56 mAb A6-220 (IgM). While the A6-136 
mAb restored lysis of protected target cells  (Table 2), A6- 
220  mAb had  no  effect  (not  shown).  These  data  support 
the notion that Q66 mAb-defined molecules represent in- 
hibitory NK receptors specific for HLA-A3 and -A11 alleles. 
To  further  investigate  the  HLA-A  allelic  specificity  of 
Q66 + clones, as well as the possible functional relationship 
with other HLA class I-specific NK receptors, we analyzed 
clones  coexpressing  Q66  and  Z27  (Bw4-specific)  mAb- 
reactive  molecules.  In  Table  3,  the  representative  clones 
A15 and A31  were tested against target cells expressing ap- 
propriate class I  alleles.  Thus,  while lysis  of C1P,-A3  was 
reconstituted by the addition  of the Q66 mAb alone,  Z27 
mAb alone was sufficient to reconstitute lysis of C IP,-B51 
and  SP0010  B-EBV  cell  line.  On  the  other  hand,  the 
B-EBV  cell  line  HOM-2,  expressing both  HLA-A3  and 
HLA-B27  (Bw4),  could  be  efficiently  lysed  only  in  the 
presence of both mAbs.  These data  indicate  that  the  two 
receptors function independently. 
Screening of a cDNA Library and Isolation of Genes Encoding 
NK  Receptors Characterized by  Three Extracellular Ig  Do- 
mains.  Since  repeated  attempts  to  immunoprecipitate 
Q66-reactive surface molecules have failed (possibly related 
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Figure 3.  HLA-A3  expression on target cells confers protection from lysis by Q66  + clones, (A) Four representative EB6-, GL183-, Z27  , Q66 § 
clones were assessed for cytolytic activity in a 4 h StCr release assay against HOM2 (HLA-A3; -B27; -Cwl), WT100BIS (HLA-AI1; -B35; -Cw4), 
SP0010 (HLA-A2; -B44; -Cw5), and A51 (HLA-A2; -B18,15; -Cw3,7) B-EBV cell lines. HOM2 and WTI00BIS target cells were resistant  to lysis, 
while SP0010 and A51 were efficiently  lysed. The E/T ratio was 4:t. Data are expressed as a percent-specific  51Cr release. (B) Four representative  EB6-, 
GL183-, Z27-, and Q66- clones were tested against HOM2 and SP0010. Both B-EBV cell lines were lysed. (C) The four Q66 + clones shown in A 
were tested against C1R cells or C1R transfected with HLA-A3, -A2, or -A1. Although not shown, C1R-A24 cells were consistently  lysed. (D) The 
four Q66-negative clones  shown in B were tested against the same target ce]ls of C. 
to the IgM isotype of Q66 and Q241 mAbs), we attempted 
to identify these molecules by isolating the cDNA encod- 
ing for Q66 molecules in Q66 § cell populations or clones. 
Since  Q66-reactive  molecules  function  as  receptors  for 
HLA class I molecules, we speculated that a possible candi- 
date could be represented by a  novel member of the p58 
family (11).  In an attempt to isolate these molecules, a 403-bp 
probe  derived from  the  5'  end of the  183  cl.6  sequence 
(nucleotides 88-491)  was  used  to  screen a  cDNA library 
generated  from  the  Q66 §  polyclonal CD3-16 +  NK  cell 
population  derived  from  a  healthy  donor.  Numerous 
cDNA  clones  were  isolated:  whereas  most  encoded  for 
GL183/EB6-reactive molecules,  two  were  found to  en- 
code for different molecules (cl. 17.1  and cl.8.11). The by- 
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pothetical  ORF  of both  c1.17.1  and  cl.8.11  cDNAs  en- 
coded for molecules belonging to the  Ig superfamily with 
three Ig-like domains, Although the c1.17.1  and cl.8.11 se- 
quences were highly homologous, there was a single amino 
acid  difference  (I  in  pos.252  instead  of  T)  and,  more 
importantly, a  17  amino acid deletion in the  extracellular 
portion proximal to the transmembrane region of cl.8.11- 
encoded protein. Both cDNAs lacked the first ATG initia- 
tion  codon.  Therefore,  to  obtain a  complete  coding se- 
quence, we applied the 5' RACE procedure, by using the 
same RNA  used for preparation of the  cDNA library. A 
full-length cDNA  (c1.17.1C)  that  corresponded to  c1.17.1 
cDNA (Fig. 4) was obtained. The ORF ofc1.17.1C cDNA 
encoded for a  455-amino acid type I transmembrane pro- Table 2.  Q66 mAb Selectively Restores Lysis of Target Cells Expressing HLA-A3 or -A 11 Alleles 
Target cell 
HOM2  WTI00BIS  SP0010 
C 1R.-A3  (A3,B27,Cwl)  (A11,B35,Cw4)  (A2,B44,Cw5) 
Added mAb  Added mAb  Added mAb  Added mAb 
Anti-HLA*  Anti-HLA 
Clone  -  Q66  class I  -  Q66  class I  -  Q66 
Anti-HLA 
class I  Q66 
Anti-HLA 
class I 
DP7  33~  64  70  9  84  80  9  79 
DP4  29  54  91  8  67  89  12  53 
DP3  27  54  72  9  64  74  7  49 
I~Pll  16  54  60  4  41  52  16  66 
75 
72 
60 
81 
80 
74 
65 
80 
88 
80 
72 
85 
94 
80 
88 
90 
*The anti-HLA class I mAb used was the A6-136 previously described (21). 
~The results are expressed as the precentage of  specific lysis in cytolytic assays at an E/T ratio of 4:1. 
tein belonging to the Ig superfamily, consisting of an extra- 
cellular region composed of 319 amino acids, characterized 
by three Ig-like domains, a 20--nonpolar amino acid trans- 
membrane portion,  and a  95-amino acid cytoplasmic tail. 
As already described for the inhibitory forms of HLA-C--spe- 
cific  receptors  (p58  molecules),  the  cytoplasmic  tail  con- 
tained  an  ITAM-hke  sequence  consisting  of two  YXXL 
motifs spaced by 26 amino acids (11-14). A  comparison of 
the nucleotide sequence of cl. 17. IC with other p58-related 
sequences  (11-14)  revealed  a  high  degree  of homology 
with NKAT4 and two other sequences encoding for recep- 
tors  characterized  by  three  extracellular  Ig-hke  domains 
(NKB1, NK_B 1B). 
Isolation  of Full-length cDNAs Encoding for Molecules  Char- 
actetized  by  Three  Ig-like  Domains  Expressed  in  Q66  +  and 
Q66- NK Cell Clones.  On the basis of the nucleotide se- 
quence of the  c1.17.1C  (and of the  other homologous se- 
quences  NKAT4,  NKB1,  and  p58),  two  PCR  primers 
were designed. The "Ig3 up" forward primer contained the 
ATG  initiation  codon,  while  the  "Ig3  down"  backward 
primer was designed in the  3'  untranslated  region.  When 
used  in  combination,  they  amplified  1.4-kb  full-length 
cDNAs.  By  the  use  of these  PCR  primers,  1.4-kb  frag- 
ments were amphfied in various NK cell clones displaying 
different specificities for HLA class  I alleles.  Two different 
groups  of 1.4-kb  cDNAs  were  amplified.  Sequences  be- 
longing  to  the  first  group  (AMB11  and  D97.10)  were 
highly homologous to the  NKB1  and  NKAT3 sequences 
(12,  13). The NKB1 cDNA was recently shown to encode 
for  a  three  Ig-hke  domain  NK  receptor  specific  for  the 
HLA-Bw4  supertypic  specificity.  Although  not  shown, 
NIH3T3  cells  transfected  with  AMB11  cDNA  were 
brightly  stained  by Z27  mAb,  thus  formally proving that 
also AMB11  cDNA encodes for the Bw4-specific NK re- 
ceptor.  The  second group  of cDNAs  (AMC5  and  c1.1.1) 
were  exclusively amplified  from Q66 §  NK cell  clones.  A 
comparison  of  the  amino  acid  sequences  of  AMC5, 
NKAT4, cl. 1.1, cl. 17.1C, AMB 11, and NKB 1 is shown in 
Fig.  4.  The  proteins  encoded  by  the  second  group  of 
cDNAs  (AMC5  and  c1.1.1)  showed  a  high  degree  of 
Table 3.  Independent  Function of HLA-A3-and Bw4-specific receptors in Q66§ Z27 + NK Cell Clones 
Target Cell 
C1R-B51  HOM2  SP0010 
C llK-A3  (Bw4)  (A3,B27,Cw1)  (A2,B44,Cw5) 
Added mAb  Added mAb  Added mAb  Added mAb 
Clone  --  Q66  Z27  Anti-cl.I*  --  Q66  Z27  Anti-cl.I  --  Q66  Z27  Z27+Q66  Anti-cl.I --  Q66  Z27  Z27+Q66 Anti-cl.l 
A15  27"  55  34  53  8  16  57  68  2  7  7  46  46  5  12  61  71  72 
A31  40  72  43  84  8  6  98  96  2  2  14  59  75  4  0  74  80  88 
*The results are expressed as the percentage of  specific lysis in cytolytic assays at an E/T ratio of  4:1. 
r  anti~LHA class I mAb used was the A6-136 mAb (21). 
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Figure 4.  Alignment of the amino acid sequences coding for either Q66 and Q241 mAbs-reactive  molecules  or other 3 Ig domain NK receptors. The 
amino acid sequences of Q66 and Q241 mAbs-reactive  molecules  encoded by AMC5 and c1.1.1 cDNA clones are compared with sequences encoded by 
c1.17.1C,  NKAT4, AMB11, and NKB1 cDNAs. Dashes were introduced  to maximize homologies.  Amino acids identical to the consensus are indicated 
by dots. The signal peptide and the transmembrane region in the consensus sequence  are underlined; pairs of cysteines predicted to form Ig domains are 
connected by a hne. Cysteines  that are possibly involved in disulphide bridge formation are indicated by arrows, cDNA sequences  have been submitted 
to EMBL with the following accession numbers: AMB11, X94262;  17.1C, X93595; 8.11C, X93596; c1.1.1, X94373; and AMC5, X94374. 
homology with  c1.17.1C  protein,  displaying  only  three 
amino  acid  differences.  On  the  other  hand,  the  protein 
sequences  of AMC5  and c1.1.1 differed from the NKB1- 
and  AMB11-encoded  protein  for  ~50  amino  acids  in 
their extracellular portions.  Moreover, both AMCS-  and 
cl. 1.1-encoded proteins displayed a cytoplasmic tail 11 amino 
acids  longer  than  that  of NKB1-  and  AMBll-encoded 
proteins (Fig. 4). 
Correlation between the  Surface Expression  of Q66-reactive 
Molecules and the Presence of Defined Sequences Encoding for a 
Group of Three Ig-like Domains Receptors.  To establish whether 
a correlation existed between the expression of Q66-reac- 
tive surface molecules and the presence of  AMC5, c1.17.1C 
and c1.1.1 cDNA sequences (i.e.,  those exclusively ampli- 
fied  from  Q66 +  clones),  an  appropriate  oligonucleotide 
probe (probe Q) has been designed. This probe was specific 
for  the  nucleotide  sequences  of  AMC5,  c1.1.1, and 
c1.17.1C  and was used to hybridize amphfied PCR prod- 
ucts from a large panel of Q66 + and Q66- NK cell clones. 
Notably, these Q66 § clones belong to the same group of 
those selected for the analysis of HLA class I alle~e specific- 
ity in cytolytic assay, i.e., those lacking other known NK 
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receptors for HLA class I molecules (see above). As shown 
in Fig. 5,  the probe  Q  hybridized with cDNA fragments 
amplified from Q66 +, but not from Q66- NK cell clones. 
Conversely, a probe specifically designed on the basis of the 
known cDNA sequences encoding for p70/NKB1  recep- 
tor (probe Z) did not hybridize with cDNA fragments am- 
phfied from Z27- Q66 + clones. On the other hand, it did 
hybridize with cDNA from Z27 + clones (not shown). 
Transient Transfections in COS7 Cell Lines.  COS7  cells 
were transfected with AMC5 or cl. 1.1  cDNAs inserted in 
the pCR3 expression vector. After 48 h, cells were stained 
with Q66, Q241, Z27, EB6, and GL183 mAbs or with ad- 
ditional control mAbs of IgM isotype. COS7  cells trans- 
fected with  AMC5  or  c1.1.1  cDNAs  were  reproducibly 
stained  by Q66  and  Q241  mAbs,  but  not by  the  other 
mAbs (data not shown). 
Generation of a Polydonal Antiserum  against Peptides Corre. 
sponding to  Sequences Unique of AMCS/d. 1. I  and d. 17. IC. 
Based on the known amino acid sequences of NK recep- 
tors displaying three Ig-like domains, we synthetized a spe- 
cific  peptide  corresponding  to  the  COOH-terminal  se- 
quence of AMC5, cl. 1.1, and cl. 17.1 proteins (amino acids Figure  5.  Amplification  of specific cDNAs from Q66  § or Q66- NK 
cell clones. The amplified fragments from Q66  + Z27- (spotted in posi- 
tions A1, A2, A3, A4, AS, A6, B1, B2, B3, and B4)  and Q66- Z27 + 
(spotted in positions B6, C1, and C2) NK clones were hybridized with 
the probe Q. These NK cell clones were derived from seven different do- 
nors. The AMB11 and D97.10 cDNAs (used as negative controls) were 
spotted in positions C3 and C4, while cl.l. l and AMC5 cDNAs  (positive 
controls) were spotted in positions C5 and C6, respectively. 
441-455).  Remarkably,  NKB1  and  NKAT3  protein  se- 
quences are characterized by a cytoplasmic tail shorter than 
that  of AMC5,  c1.1.1  and  c1.17.1,  which  stops  at  amino 
acid  444.  The  441-455  peptide  was  used  to  imnmnize  a 
rabbit.  The  antiserum  obtained  (termed PGP3)  was found 
to react with the  immunizing peptide  but not with  irrele- 
vant  peptides  (not shown).  PGP3  was  used  to  analyze,  in 
Western blot, a panel of Q66 + or Q66-  NK cell lines; un- 
der nonreducing conditions, Q66 + NK cells displayed 140- 
kD molecules that resolved in a single band of 70 kD under 
reducing  conditions  (molecules  were  therefore  termed 
"p140").  No p140  molecules  could be  detected  in  Q66- 
NK cells  (independent on the expression ofp70/NKB1  re- 
ceptors)  (Fig. 6).  Similar data were obtained by the analysis 
of Q66 +  polyclonal  populations  derived  from  two  addi- 
tional donors. These results strongly suggest that PGP3 spe- 
cifically  recognizes  the  proteins  encoded  by  AMC5  and 
cl. 1.1  cDNAs. 
Biochemical Analysis of cl. 1. I-encoded Molecules Expressed by 
NIH3T3 Cell Transfectants.  To characterize  the p140 mol- 
ecules encoded by cl. 1.1  cDNA, we analyzed the proteins 
expressed by the murine NIH3T3 cells  transfected with the 
pCR3  c1.1.1  construct.  As  shown  in  Fig.  7,  upper panel, 
only  transfected  cells  were  brightly  stained  by  Q66  and 
Q241 mAbs, but not by other mAbs, including the p58- or 
p70-reactive EB6,  GL183,  or Z27 mAbs.  In addition,  the 
mean fluorescence detected in cell transfectants was similar 
to  that  of Q66 +  NK  cell  clones for both  Q66  and  Q241 
mAbs.  These  data further  confirm that both mAbs recog- 
nize the  same  molecule.  No staining  could be  detected  in 
NIH3T3 cells  transfected with other constructs for p58  or 
p70 molecules  (data not shown).  NIH3T3 cells  either un- 
transfected  or transfected  with  c1.1.1  were  lysed  and  total 
cell  lysates  were  analyzed  by  Western  blot  by  using  the 
PGP3  antiserum.  As  shown  in  Fig.  7,  lower panel, under 
nonreducing conditions (NR), two bands of 140 and 70 kD 
were detectable in NIH3T3 cells transfected with c1.1.1  (B) 
and in a Q66 + NK cell polyclonal population  (C), but not 
in  untransfected  NIH3T3  cell  line  (A).  Moreover,  under 
reducing conditions  (R),  only a 70-kD band could be  de- 
Figure 6.  Western  blot analysis of Q66 + or Q66- NK cells. Western 
blot analysis of total cell lysates was performed in Q66 + NK cell poly- 
clonal populations (lanes A) and in the Q66  NK3.3  cell line (lanes B). 
SI)S-PAGE was performed under reducing (lk) or nonreducing (NP,) 
conditions. Molecular mass markers (expressed in kilodaltons) are indi- 
cated. PGP3 polyclonal  antiserum was used to stain the blot, followed by 
a chemiluminescence detection system. 
tected in the cl.l.l-transfected NIH3T3 cell line (B) and in 
the polyclonal Q66 +  NK cell population  (C), see also Fig. 
6.  Thus, by comparison with  the p70 receptor recognized 
by Z27 mAb, the molecular weight of the p140 molecules 
detected by PGP3 antiserum is consistent with a dimer of 3 
Ig domain molecules. Since NIH3T3 cells transfected with 
c1.1.1  are brightly stained by Q66 and Q241  mAbs, but not 
by other mAbs specific for p58 or p70 NK receptors,  these 
data  strongly  suggest  that  c1.1,1  encodes  for  Q66-  and 
Q241-reactive  molecules.  Thus,  data  in  both  Q66 +  NK 
cell populations and in NIH3T3 cell transfectants  are con- 
sistent with the expression of  p140 molecules as disulphide- 
linked dimers.  This finding is consistent with the presence, 
in the corresponding sequences, of  two cysteins at positions 
302 and 336, respectively (see  Fig. 4). 
Discussion 
In the present study, we identified a novel surface mole- 
cule expressed by a subset of  human NK cells that functions 
as  receptor  specific  for defined  HLA-A alleles.  Molecular 
cloning revealed a high degree of homology with the p58/ 
p70 titmily of NK receptors for HLA class I molecules (11- 
13). This receptor is characterized by three Ig-like extracel- 
lular  domains,  a  transmembrane  portion  of 20  nonpolar 
residues and a 95-amino acid tail containing an ITAM-like 
motif. Remarkably, different from the previously identified 
p58/p70  receptors,  it  can  be  expressed  as  a  disulphide- 
linked dimer of~140  kD ("p140"). 
NK receptors specific for different groups of HLA-C and 
HLA-B  alleles  have  recently  been  described  and  cloned. 
They function as inhibitory receptors which, upon binding 
their  appropriate  HLA class  I  ligand,  transduce  a  negative 
signal to the NK cell, thus inhibiting target cell lysis  (2,  11, 
12).  An  activatory  form  of HLA-C-specific  receptor  has 
514  The HLA-A-specific Natural  Killer Receptor Is a 140-kD Dimer Figure  7.  Cell-surface  expression and 
Western  blot  analysis of Q66  and  Q241 
mAb-reactive proteins in cell transfectants. 
(Top) NIH3T3 cell line either untransfected 
or transfected with  cl.  1.1. NIH3T3  cells 
were trypsinized, stained with Q66 or Q241 
mAb, followed by a PE-conjugated goat an- 
tibody to  mouse IgM or GL183, EB6, or 
Z27, followed by a goat antibody to mouse 
lgG,  and  analyzed by  FACSort  |  (Becton 
Dickinson).  lsotype-matched  mouse  Ig 
were used as controls. Dark profiles repre- 
sent cells stained with  the  indicated mAb. 
White  profiles represent  controls  stained 
with  the  second  reagent  only.  (Bottom) 
Western blot analysis of total cell lysates of 
the  NIH3T3  cell  line  untransfected  (A), 
transfected with pCR3 cl. 1.1. (B), or of a 
Q66 + NK  cell polyclonal population  (C). 
SDS-PAGE  was  performed  under  nonre- 
ducing (/ej~) or reducing  (right) conditions. 
Molecular mass markers (expressed in kilo- 
dahons) are indicated. PGP3 polyclonal an- 
tiserum was used to stain the blot, followed 
by a chemiluminescence detection system. 
recently been described (14, 30).  However, this receptor is 
expressed  only  by  certain  individuals,  and  it  differs  from 
conventional  inhibitory  receptors  in  the  transmembrane 
and cytoplasmic portions. 
Litwin et  al.  (10)  have  previously described clones spe- 
cific for different HLA-A alleles, including -A1, -A3, and 
-A69.  Our present study provides the  first molecular evi- 
dence for the existence of defined receptors for HLA-A al- 
leles.  Similar to  the  other  HLA  class  I-specific receptors, 
the  NK  receptor for  HLA-A3 is expressed by a  subset of 
NK  cells, functions  as an inhibitory receptor,  and may be 
coexpressed  with  other  NK  receptors  at  the  single-cell 
level. Although present in all donors tested, its level of ex- 
pression may be low. It should be noted that an unequivo- 
cal  HLA-A3  specificity could  be  detected  only in  clones 
brightly stained by Q66  mAb.  This finding is in line with 
data on other NK receptors,  e.g., it has been shown  that a 
critical number ofp58.1  (EB6)  molecules is needed to pro- 
vide an efficient inhibitory signal to NK cells (5). 
The specificity of p140 molecules for HLA-A3 or -A11 
alleles has been clearly demonstrated by a number of exper- 
iments  performed on  C1R  cells transfected with  different 
HLA class I  alleles or B-EBV cell lines expressing an infor- 
515  Pende et al. 
mative HLA class I haplotype. It should be stressed that we 
selected Q66 + NK cell clones displaying specificity only for 
HLA-A3 molecules. Consistently, these clones did not ex- 
press p58  or p70/NKB1  molecules but did express CD94 
molecules.  In these clones, however,  anti-CD94  mAb did 
not  restore  lysis of HLA-A3  +  target  cells.  These  selected 
Q66 + clones did not lyse cells expressing HLA-A3 or -A1 l, 
but lysed cells lacking these  alleles.  In  all instances,  target 
cells transfected with  different HLA-C  or -B  alleles were 
efficiently lysed by Q66 +  clones.  The  specificity of p140 
molecules for HLA-A3 or -A11 alleles was further substan- 
tiated by the ability of Q66 mAb to selectively restore lysis 
of  HLA-A3  +  target  cells  by  Q66 +  clones.  Analysis  of 
clones coexpressing p140 and p58 or p70/NKB1  receptors 
indicated that p140  molecules were  not physically associ- 
ated to any of these receptors.  For example, mAb-induced 
modulation  of p58.1  molecules  did  not  affect  the  surface 
expression ofpl40  molecules. In addition, the receptors for 
Bw4  (p70/NKB1)  and  those  for  HLA-A3  (p140)  were 
functionally  independent  as  shown  by  the  analysis  of 
Z27+Q66 §  clones.  Thus,  when  tested  against target  cells 
coexpressing HLA-Bw4  and  HLA-A3 alleles (see,  for  ex- 
ample,  the  cell line  HOM-2),  lysis was  achieved  only by mAb-mediated masking of both receptors (Table 3).  Simi- 
lar results were obtained by the analysis of cell transfectants. 
Thus,  Q66  mAb  could  restore  lysis  only  when  tested 
against C1R-A3, but not against CIR.-B27. R~estoration of 
lysis  of C1K-B27  required  the  addition  of Z27  mAb.  A 
similar functional independency was observed in clones co- 
expressing p140 and p58 receptors (not shown). Taken to- 
gether, these data indicate that p140 functions as an inhibi- 
tory  receptor  for  HLA-A3  or  -All  alleles,  but  not  for 
HLA-C or -B alleles.  In addition,  the finding that at least 
three different HLA-A alleles  (-A1, -A2, and -A24) did not 
confer protection from Q66 +  clones clearly indicates that 
p140 receptor discriminates among HLA-A alleles.  In this 
context,  comparative analysis of the sequences of HLA-A 
alleles  indicates that HLA-A3 and -All  molecules display 
the highest homology in the amino acid sequences corre- 
sponding to the oL1 domain (i.e., a region known to be in- 
volved in the NK-mediated recognition of HLA-C or -B 
alleles),  t~emarkably, -A3  and  -All  alleles  did  not  differ 
from the -A2 allele in the amino acid positions 77 and 80, 
despite the different ability to provide target cell protection 
from Q66 + clones. Thus, the amino acid positions 77 and 
80 are not crucial for the  NK-mediated recognition,  as it 
occurs for HLA-C alleles. 
Analysis of the molecular structure of the p140 molecule 
revealed a new member of the p58/p70 family of NK recep- 
tors  displaying three  extracellular  Ig-like domains.  How- 
ever, this receptor is expressed as a disulphide-linked dimer 
of 140 kD. This suggests that recognition of HLA-A3 mol- 
ecules may be mediated by the receptor in its dimeric form. 
Analysis  of the  amino  acid  sequences  deduced  from  the 
cDNA nucleotide  sequences showed two cysteines in the 
extracellular portion of p140 molecules proximal to the tram- 
membrane region,  thus  differing from the  other p58/p70 
members.  These  cysteines  may explain  the  expression  of 
p140 as a disulphide-linked dimer. Notably, the p140 form 
is the prevalent or the exclusive form detectable in Q66 + 
polyclonal NK cell population,  while both p140  and p70 
are  well  represented  in  NIH3T3  cells  transfected  with 
cDNA c1.1.1.  This could reflect a less efficient assembly of 
monomers in cell tranffectants.  Interestingly, the  ORF  of 
cl.8.11C  and c1.17.1C  differed by a deletion of 17  amino 
acids  in  the  extracellular  portion  proximal  to  the  trans- 
membrane region of cl.8.11C.  A  similar deletion has been 
described by D'Andrea et al. in the NKB1/NKBIB mole- 
cules (12).  The mechanism involved in this deletion occur- 
ring in three Ig-like domains receptors remains to be defined, 
although a possible explanation could be a mechanism in- 
volving an  alternative  splicing.  The  isolation  of different 
cDNAs  for highly  homologous proteins,  all reactive with 
Q66 and Q241  mAbs, is compatible with the existence of 
allelic forms of the receptors. Notably, the existence of mul- 
tiple homologous forms of receptors has been described also 
for p58 and p70/NKB1  (3I). 
In  the  present  study,  we  describe  only  the  inhibitory 
form of the  receptor specific for HLA-A3  or -All.  We 
cannot exclude the existence of an activatory form of this 
receptor,  as  was  recently shown  for the  HLA-C-specific 
receptors. We did not address this issue in the present study 
because of the IgM isotype of Q66 and Q241 mAbs, which 
could  not  be  tested  in  a  redirected  killing  assay.  We  are 
presently investigating whether sequences typical of the ac- 
tivatory forms of the NK receptors are present in a panel of 
Q66 + clones from different individuals. 
Interestingly, similar to p58  or p70,  the  HLA-A3--spe- 
cific receptors  are  also  expressed in  a  small fraction  of T 
cells. It is likely that they could exert an inhibitory function 
on  TCR-mediated  T  cell activation,  as previously docu- 
mented for both p58 or p70 (23-25). 
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